y GenPharm International Inc., of Mountain View, Calif., was issued aU.S. patent, No. 5,304,489, titled "DNA Sequences to Target Proteinsto the Mammary Gland for Efficient Secretion." It disclosesfundamental technology based on casein promoters, which are widelyused for the production of therapeutic proteins, especially humanproteins, in the milk of transgenic animals.y ProCyte Corp., of Kirkland, Wash., received a notice of patentallowance for its claim for certain cosmetic skin treatmentcompositions. The patent covers the company's copper-basedcompounds used in tissue repair technology.
(c) 1997 American Health Consultants. All rights reserved.